Skip to main content
logo
Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
18.56
-0.31 (-1.64%)
Sep 15, 2025, 10:33 AM EDT - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Monoclonal Antibody
302.00K
Log In
Log In
Log In
Log In
Upgrade
Monoclonal Antibody Growth
-3.82%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
302.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-3.82%
Log In
Log In
Log In
Log In
Upgrade